Rationale and Design of the Chronic GVHD Cohort Study: Improving Outcomes Assessment in Chronic GVHD

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 8, 2011, Pages 1114-1120

[No Author Info available]

Author keywords

Allogeneic hematopoietic cell transplantation; Chronic graft versus host disease; Observational clinical study; Outcomes research

Indexed keywords

ABSTRACT REPORT; ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ASSESSMENT; DISEASE ACTIVITY; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; METHODOLOGY; MULTICENTER STUDY (TOPIC); MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; NONMYELOABLATIVE CONDITIONING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROGNOSIS; PROSPECTIVE STUDY; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; DATA COLLECTION; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960234742     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.05.007     Document Type: Article

References (35)

1. Flowers M.E., Parker P.M., Johnston L.J., et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 2002, 100:415-419.
2. Lee S.J., Flowers M.E. Recognizing and managing chronic graft-versus-host disease. Hematology Am Soc Hematol Educ Program 2008, 134-141.
3. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980, 69:204-217.
4. Arora M., Burns L.J., Davies S.M., et al. Chronic graft-versus-host disease: a prospective cohort study. Biol Blood Marrow Transplant 2003, 9:38-45.
5. Lee S.J., Vogelsang G., Flowers M.E. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003, 9:215-233.
6. Fraser C.J., Bhatia S., Ness K., et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood 2006, 108:2867-2873.
7. Kiss T.L., Abdolell M., Jamal N., Minden M.D., Lipton J.H., Messner H.A. Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. J Clin Oncol 2002, 20:2334-2343.
8. Pidala J., Kurland B., Chai X., et al. Patient reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium. Blood 2011, 117:4651-4657.
9. Stewart B.L., Storer B., Storek J., et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 2004, 104:3501-3506.
10. Lee S.J., Klein J.P., Barrett A.J., et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 2002, 100:406-414.
11. Couriel D., Carpenter P.A., Cutler C., et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 2006, 12:375-396.
12. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
13. Martin P.J., Weisdorf D., Przepiorka D., et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group Report. Biol Blood Marrow Transplant 2006, 12:491-505.
14. Pavletic S.Z., Martin P., Lee S.J., et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report. Biol Blood Marrow Transplant 2006, 12:252-266.
15. Schultz K.R., Miklos D.B., Fowler D., et al. Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. Biomarker Working Group Report. Biol Blood Marrow Transplant 2006, 12:126-137.
16. Shulman H.M., Kleiner D., Lee S.J., et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant 2006, 12:31-47.
17. Jacobsohn D.A., Chen A.R., Zahurak M., et al. Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease. J Clin Oncol 2007, 25:4255-4261.
18. Flowers M.E., Apperley J.F., van Besien K., et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood 2008, 112:2667-2674.
19. Greinix H.T., Pohlreich D., Maalouf J., et al. A single-center pilot validation study of a new chronic GVHD skin scoring system. Biol Blood Marrow Transplant 2007, 13:715-723.
20. Carpenter PA. How to Conduct a Comprehensive Chronic GVHD Assessment. Available at: 2011. http://www.fhcrc.org/science/clinical/gvhd/.
21. Pavletic S, Cowen E, Correa E, Mitchell S, Thormann K, Jacobsohn D. Evaluating therapeutic response in chronic GVHD. Available at: 2010. http://rarediseasesnetwork.epi.usf.edu/training/confevents.asp%3fConfID%3d6501.
22. McQuellon R.P., Russell G.B., Cella D.F., et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 1997, 19:357-368.
23. Ware J.E., Kosinski M., Keller S.D. SF-36 Physical and Mental Health Summary Scales: A User's Manual 1994, The Health Institute, New England Medical Center, Boston, MA.
24. Ware J.E., Snow K.K., Kosinski M., Gandek B. SF-36 Health Survey: A Manual and Interpretation Guide 1993, The Health Institute, New England Medical Center, Boston, MA.
25. Lee S., Cook E.F., Soiffer R., Antin J.H. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2002, 8:444-452.
26. Daughton D.M., Fix A.J., Kass I., Bell C.W., Patil K.D. Maximum oxygen consumption and the ADAPT quality-of-life scale. Arch Phys Med Rehabil 1982, 63:620-622.
27. Herzberg P.Y., Heussner P., Mumm F.H., et al. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010, 16:1707-1717.
28. Schiffman R.M., Christianson M.D., Jacobsen G., Hirsch J.D., Reis B.L. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000, 118:615-621.
29. Young N.L. Activities Scale for Kids 2006, Manual.
30. Young N.L., Williams J.I., Yoshida K.K., Wright J.G. Measurement properties of the activities scale for kids. J Clin Epidemiol 2000, 53:125-137.
31. Sorror M.L., Maris M.B., Storb R., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005, 106:2912-2919.
32. Groll D.L., To T., Bombardier C., Wright J.G. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 2005, 58:595-602.
33. Arnold A.M., Kronmal R.A. Multiple imputation of baseline data in the cardiovascular health study. Am J Epidemiol 2003, 157:74-84.
34. Leisenring W.M., Mertens A.C., Armstrong G.T., et al. Pediatric cancer survivorship research: experience of the Childhood Cancer Survivor Study. J Clin Oncol 2009, 27:2319-2327.
35. Chronic GVHD Consortium. Available at: http://rarediseasesnetwork.epi.usf.edu/index.htm.